References
- Bousquet J, van Cauwenberge P, Khaltaev N; ARIA Workshop Group. Allergic rhinitis and its impact on asthma. J. Allergy Clin. Immunol.108, S147–S334 (2001).
- Scadding GK, Richards DH, Price MJ. Patient and physician perspective on the impact and management of perennial and seasonal allergic rhinitis. Clin. Otolaryngol.25, 551–557 (2000).
- Portnoy JM, Van Osdol T, Williams PB. Evidence-based strategies for treatment of allergic rhinitis. Curr. Allergy Asthma Rep.4, 439–446 (2004).
- Chalmers GW, Macleod KJ, Little SA, Thomson LJ, McSharry CP, Thomson NC. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax57(3), 226–230 (2002).
- Tomlinson JE, McMahon AD, Chaudhuri R, Thompson JM, Wood SF, Thomson NC. Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax60, 282–287 (2005).
- Bousquet J; ARIA Workshop Group. Topical Glucocorticosteroids. J. Allergy Clin. Immunol.108, 230–234 (2001).
- Scadding GK, Durham SR, Mirakian R et al.; British Society for Allergy and Clinical Immunology. BSACI guidelines for the management of allergic and non-allergic rhinitis. Clin. Exp. Allergy38(1), 19–42 (2008).
- Waddell AN, Patel SK, Toma AG, Maw AR. Intranasal steroid sprays in the treatment of rhinitis: is one better than another? J. Laryngol. Otol.117, 843–845 (2003).
- Lanier B, Kai G, Marple B, Wall GM. Pathophysiology and progression of nasal septal perforation. Ann. Allergy Asthma Immunol.99(6), 473–479 (2007).